中国卒中杂志 ›› 2021, Vol. 16 ›› Issue (10): 1067-1074.DOI: 10.3969/j.issn.1673-5765.2021.10.016
刘颖, 丁晶, 汪昕
收稿日期:
2021-04-05
出版日期:
2021-10-20
发布日期:
2021-10-20
通讯作者:
汪昕 wang.xin@zs-hospital.sh.cn
基金资助:
Received:
2021-04-05
Online:
2021-10-20
Published:
2021-10-20
摘要: 血管内治疗是急性大血管闭塞性卒中的重要治疗手段。有研究表明,超过40%接受血管内 治疗的患者虽然术后血管造影显示闭塞的颅内动脉已实现再通,但不能获得90 d功能独立,即无效再 通。无效再通严重影响血管内治疗的疗效,近年来逐渐引起临床重视。目前多项研究对无效再通的 相关机制及影响因素展开了探索,旨在寻找有效的干预措施,减少无效再通的发生,为改善血管内治 疗患者的预后提供依据。
刘颖, 丁晶, 汪昕. 急性缺血性卒中血管内治疗无效再通的研究进展[J]. 中国卒中杂志, 2021, 16(10): 1067-1074.
LIU Ying, DING Jing, WANG Xin. Advances in Futile Recanalization of Endovascular Thrombectomy for Acute Ischemic Stroke[J]. Chinese Journal of Stroke, 2021, 16(10): 1067-1074.
[1] 王拥军,李子孝,谷鸿秋,等. 中国卒中报告2019(中 文版)(1)[J]. 中国卒中杂志,2020,15(10):1037- 1043. [2] 王拥军,李子孝,谷鸿秋,等. 中国卒中报告2019(中 文版)(2)[J]. 中国卒中杂志,2020,15(11):1145- 1155. [3] SMITH W S,LEV M H,ENGLISH J D,et al. Significance of large vessel intracranial occlusion causing acute ischemic stroke and TIA[J]. Stroke, 2009,40(12):3834-3840. [4] POWERS W J,RABINSTEIN A A,ACKERSON T,et al. 2018 guidelines for the early management of patients with acute ischemic stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J/OL]. Stroke,2018,49(3):e46-e110[2021-03-16]. https://doi.org/10.1161/str.0000000000000158. [5] ALBERS G W,MARKS M P,KEMP S,et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging[J]. N Engl J Med, 2018,378(8):708-718. [6] NOGUEIRA R G,JADHAV A P,HAUSSEN D C, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct[J]. N Engl J Med,2018,378(1):11-21. [7] VAN HORN N,KNIEP H,LEISCHNER H,et al. Predictors of poor clinical outcome despite complete reperfusion in acute ischemic stroke patients[J]. J Neurointerv Surg,2021,13(1):14-18. [8] HUSSEIN H M,GEORGIADIS A L,VAZQUEZ G,et al. Occurrence and predictors of futile recanalization following endovascular treatment among patients with acute ischemic stroke:a multicenter study[J]. Am J Neuroradiol,2010,31(3): 454-458. [9] YOO A J,SIMONSEN C Z,PRABHAKARAN S,et al. Refining angiographic biomarkers of revascularization:improving outcome prediction after intra-arterial therapy[J]. Stroke,2013,44(9): 2509-2512. [10] TOMSICK T,BRODERICK J,CARROZELLA J, et al. Revascularization results in the interventional management of stroke II trial[J]. Am J Neuroradiol, 2008,29(3):582-587. [11] HUSSEIN H M,SALEEM M A,QURESHI A I. Rates and predictors of futile recanalization in patients undergoing endovascular treatment in a multicenter clinical trial[J]. Neuroradiology,2018, 60(5):557-563. [12] ZAIDAT O O,YOO A J,KHATRI P,et al. Recommendations on angiographic revascularization grading standards for acute ischemic stroke[J]. Stroke,2013,44(9):2650-2663. [13] GOYAL M,MENON B K,VAN ZWAM W H,et al. Endovascular thrombectomy after large-vessel ischaemic stroke:a meta-analysis of individual patient data from five randomised trials[J]. Lancet, 2016,387(10029):1723-1731. [14] CASETTA I,FAINARDI E,SAIA V,et al. Endovascular thrombectomy for acute ischemic stroke beyond 6 hours from onset[J]. Stroke,2020,51 (7):2051-2057. [15] LIU X F,DAI Q L,YE R D,et al. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion(BEST):an openlabel, randomised controlled trial[J]. Lancet Neurol, 2020,19(2):115-122. [16] DE MEYER S F,DENORME F,LANGHAUSER F,et al. Thromboinflammation in stroke brain damage[J]. Stroke,2016,47(4):1165-1172. [17] DE WAHA S,PATEL M R,GRANGER C B,et al. Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction:an individual patient data pooled analysis from seven randomized trials[J]. Eur Heart J,2017,38(47):3502-3510. [18] WU M Y,YIANG G T,LIAO W T,et al. Current mechanistic concepts in ischemia and reperfusion injury[J]. Cell Physiol Biochem,2018,46(4):1650- 1667. [19] SUN M S,JIN H,SUN X,et al. Free radical damage in ischemia-reperfusion injury:an obstacle in acute ischemic stroke after revascularization therapy[J/ OL]. Oxid Med Cell Longev,2018:3804979[2021- 03-16]. https://doi.org/10.1155/2018/3804979. [20] MCGARRY T,BINIECKA M,VEALE D J,et al. Hypoxia,oxidative stress and inflammation[J/OL]. Free Radic Biol Med,2018,125:15-24[2021-03-16]. https://doi.org/10.1016/j.freeradbiomed.2018.03.042.
[21] DE PASCALI F,HEMANN C,SAMONS K,et |
[1] | 王磊, 周春亭, 方洋, 王朝晖. 2例椎动脉漂浮血栓的治疗体会[J]. 中国卒中杂志, 2022, 17(11): 1247-1251. |
[2] | 向薇, 徐璐瑶, 张曼曼, 魏红春, 梁志刚. 缺血性卒中急性期磁敏感加权成像不对称突出静脉征的发生率及影响因素分析[J]. 中国卒中杂志, 2022, 17(10): 1097-1102. |
[3] | 张伯煜, 郭玉成, 崔玉霞, 李英丽, 吕雨梅. 急性缺血性卒中患者就医行为决策现状及影响因素研究进展[J]. 中国卒中杂志, 2022, 17(10): 1127-1132. |
[4] | 吴亭亭, 刘亚飞, 闫世曦, 武一平, 张忠波, 张邯菲, 房娉平. “互联网+”在急性缺血性卒中救治中的应用进展[J]. 中国卒中杂志, 2022, 17(10): 1133-1138. |
[5] | 温少红, 刘宽, 赵顺英, 董雯, 陈青芳, 陈文涛, 叶维贞, 姜鸣钰, 刘向荣. 毛柳苷在脑缺血再灌注后抑制神经元自噬及神经保护作用研究[J]. 中国卒中杂志, 2022, 17(09): 991-1001. |
[6] | 温少红, 刘向荣, 赵顺英, 董雯, 陈青芳, 陈文涛, 李子孝, 王春娟. 阿司匹林和氯吡格雷联合应用 对小鼠脑缺血恢复期RAGE及 sRAGE表达的影响[J]. 中国卒中杂志, 2022, 17(08): 821-828. |
[7] | 刘承春, 唐春花, 黄书翰, 吴娅, 李小树, 李玮, 张猛. 伴大核心梗死的前循环串联闭塞的急性期同期血管内治疗研究[J]. 中国卒中杂志, 2022, 17(08): 834-839. |
[8] | 何俊芳, 刘新平, 吕学海, 王斌. PI3K/AKT信号通路介导脂联素对脑缺血再灌注大鼠的保护作用 [J]. 中国卒中杂志, 2022, 17(08): 857-862. |
[9] | 中国卒中学会神经介入分会. 症状性颅内动脉粥样硬化性狭窄血管内治疗中国专家共识2022[J]. 中国卒中杂志, 2022, 17(08): 863-888. |
[10] | 刘子悦, 朱以诚. 院内卒中再灌注治疗研究进展[J]. 中国卒中杂志, 2022, 17(07): 695-705. |
[11] | 洪月慧, 韩广淞, 吴娟娟, 沙宇惠, 付瀚辉, 周立新, 朱以诚, 倪俊. 优化院内卒中救治体系对院内缺血性卒中再灌注治疗与预后的影响:单中心回顾性研究[J]. 中国卒中杂志, 2022, 17(07): 706-710. |
[12] | 郑玮, 翟华筝, 陈萌萌, 汪敬业. 直接取栓与桥接治疗对急性大血管闭塞性缺血性卒中疗效比较的荟萃分析[J]. 中国卒中杂志, 2022, 17(07): 720-729. |
[13] | 崔晓玉, 聂曦明, 刘丽萍. 急性缺血性卒中血管内治疗术后血清前白蛋白水平与预后的相关性研究[J]. 中国卒中杂志, 2022, 17(07): 758-763. |
[14] | 周娟, 谭云宾, 王铁军, 石富铭, 余苹. 急性缺血性卒中患者住院期间照顾者焦虑抑郁的发生率及影响因素分析[J]. 中国卒中杂志, 2022, 17(07): 764-768. |
[15] | 玄桂英, 范彩丽, 玄丽霞, 赵倩倩, 李雪梅. 新型冠状病毒肺炎疫情期间急性缺血性卒中患者门诊随诊失访原因分析[J]. 中国卒中杂志, 2022, 17(06): 648-652. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||